Nalaganje...
A Prospective, Open-Label, Observational, Postmarket Study Evaluating VYC-17.5L for the Correction of Moderate to Severe Nasolabial Folds Over 12 Months
BACKGROUND: VYC-17.5L (17.5 mg/mL hyaluronic acid, 0.3% lidocaine) is a dermal filler intended for deep dermis injection for the treatment of skin depressions. OBJECTIVE: To evaluate 12-month effectiveness and safety of VYC-17.5L for the treatment of moderate/severe nasolabial folds (NLFs). METHODS:...
Shranjeno v:
izdano v: | Dermatol Surg |
---|---|
Main Authors: | , , , , , , , |
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
Lippincott Williams & Wilkins
2017
|
Teme: | |
Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5414733/ https://ncbi.nlm.nih.gov/pubmed/28165349 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/DSS.0000000000000939 |
Oznake: |
Označite
Brez oznak, prvi označite!
|